We’ve been entrusted to invest client money for nearly 40 years

 

 

Boutique investment manager with a global presence

Maple-Brown Abbott has significantly evolved since our origins nearly 40 years ago across investment styles, asset classes, geographies and client types. Today we are a boutique of boutiques, focusing on active management of differentiated listed equity strategies. As one of the earliest Australian managers to sign up to the UN PRI, we have a long history of deep ESG integration which is core to each of our strategies.

We are privately owned with around 60 staff in Sydney with around A$9 billion in assets under management as at 31 December 2023.

Vijay Srinivasan, Simon Beram and Melanie McQuire | Maple-Brown Abbott
Great Ocean Road view from a helicopter

We integrate ESG considerations across all of our investment strategies


As an investment manager with a long-term investment horizon, Maple-Brown Abbott believes that responsible investing enhances our investment decision-making and ultimately leads to superior long-term returns for our clients.

Your future, our focus

Light bulb
Excellence

We aim to work as a high performing team to achieve excellence in our investment outcomes, communications with clients, quality of our administration, IT competency and compliance.

Client focus

We seek to provide our clients with the highest level of service and accurate and timely investment information. We provide products that are attractive, competitive and in our clients' best long-term interest.

Integrity

We always act with integrity and the highest ethical standards. Our team is open and honest in all actions and communications.

Transparency

We seek to maintain transparent relationships with our clients and one another. We encourage honest feedback from all groups.

increased wealth
Creating wealth

We are in the business of creating wealth for our clients. We aim to be an employer which provides opportunity, job satisfaction and security for our employees.

Subscribe to receive Investment Insights

Subscribe